PURPOSE: First-degree relatives (FDRs) of prostate cancer (PC) patients should consider multiple concurrent personal risk factors when engaging in informed decision making (IDM) about PC screening. This study assessed perceptions of IDM recommendations and risk-appropriate strategies for IDM among FDRs of varied race/ethnicity. DESIGN: A cross-sectional, qualitative study design was used. SETTING: Study setting was a cancer center in southwest Florida. PARTICIPANTS: The study comprised 44 participants (24 PC patients and 20 unaffected FDRs). METHOD: Focus groups and individual interviews were conducted and analyzed using content analysis and constant comparison methods. RESULTS: Patients and FDRs found the PC screening debate and IDM recommendations to be complex and counterintuitive. They overwhelmingly believed screening saves lives and does not have associated harms. There was a strongly expressed need to improve communication between patients and FDRs. A single decision aid that addresses the needs of all FDRs, rather than one separating by race/ethnicity, was recommended as sufficient by study participants. These perspectives guided the development of an innovative decision aid that deconstructs the screening controversy and IDM processes into simpler concepts and provides step-by-step strategies for FDRs to engage in IDM. CONCLUSION: Implementing IDM among FDRs is challenging because the IDM paradigm departs from historical messages promoting routine screening. These contradictions should be recognized and addressed for men to participate effectively in IDM. A randomized pilot study evaluating outcomes of the resulting decision aid is underway.
PURPOSE: First-degree relatives (FDRs) of prostate cancer (PC) patients should consider multiple concurrent personal risk factors when engaging in informed decision making (IDM) about PC screening. This study assessed perceptions of IDM recommendations and risk-appropriate strategies for IDM among FDRs of varied race/ethnicity. DESIGN: A cross-sectional, qualitative study design was used. SETTING: Study setting was a cancer center in southwest Florida. PARTICIPANTS: The study comprised 44 participants (24 PC patients and 20 unaffected FDRs). METHOD: Focus groups and individual interviews were conducted and analyzed using content analysis and constant comparison methods. RESULTS:Patients and FDRs found the PC screening debate and IDM recommendations to be complex and counterintuitive. They overwhelmingly believed screening saves lives and does not have associated harms. There was a strongly expressed need to improve communication between patients and FDRs. A single decision aid that addresses the needs of all FDRs, rather than one separating by race/ethnicity, was recommended as sufficient by study participants. These perspectives guided the development of an innovative decision aid that deconstructs the screening controversy and IDM processes into simpler concepts and provides step-by-step strategies for FDRs to engage in IDM. CONCLUSION: Implementing IDM among FDRs is challenging because the IDM paradigm departs from historical messages promoting routine screening. These contradictions should be recognized and addressed for men to participate effectively in IDM. A randomized pilot study evaluating outcomes of the resulting decision aid is underway.
Entities:
Keywords:
Decision Aid; Family History; First-Degree Relatives; Health Promotion; Health focus: social health; Informed Decision Making; Manuscript format: research; Outcome measure: behavioral; Prevention Research; Prostate Cancer; Research purpose: descriptive; Setting: clinical/health care; Strategy: education, skill building/behavior change, and culture change; Study design: qualitative; Target population age: adults; Target population circumstances: race/ethnicity and male first-degree relatives
Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245
Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245
Authors: Robert J Volk; Sarah T Hawley; Suzanne Kneuper; E Wayne Holden; Leonardo A Stroud; Crystale Purvis Cooper; Judy M Berkowitz; Lawrence E Scholl; Smita S Saraykar; Valory N Pavlik Journal: Am J Prev Med Date: 2007-11 Impact factor: 5.043
Authors: Timothy J Wilt; Roderick MacDonald; Indulis Rutks; Tatyana A Shamliyan; Brent C Taylor; Robert L Kane Journal: Ann Intern Med Date: 2008-02-04 Impact factor: 25.391
Authors: Stacy N Davis; Steven K Sutton; Susan T Vadaparampil; Cathy D Meade; Brian M Rivers; Mitul V Patel; Javier F Torres-Roca; Randy V Heysek; Philippe Spiess; Julio Pow-Sang; Paul B Jacobsen; Clement K Gwede Journal: Contemp Clin Trials Date: 2014-10-23 Impact factor: 2.226
Authors: Laura J James; Germaine Wong; Jonathan C Craig; Camilla S Hanson; Angela Ju; Kirsten Howard; Tim Usherwood; Howard Lau; Allison Tong Journal: PLoS One Date: 2017-11-28 Impact factor: 3.240
Authors: Melissa R Partin; Sarah E Lillie; Katie M White; Timothy J Wilt; Kristin L Chrouser; Brent C Taylor; Diana J Burgess Journal: Health Expect Date: 2016-11-02 Impact factor: 3.377
Authors: Siddhartha Roy; Clement K Gwede; Teri L Malo; Courtney L Scherr; Selina Radlein; Cathy D Meade; Susan T Vadaparampil; Jong Y Park Journal: Am J Mens Health Date: 2020 May-Jun
Authors: Amit G Singal; Sruthi Patibandla; Joseph Obi; Hannah Fullington; Neehar D Parikh; Adam C Yopp; Jorge A Marrero Journal: Clin Gastroenterol Hepatol Date: 2020-09-10 Impact factor: 13.576